A proton is one of the subatomic particles that make up the nucleus of an atom. As small as protons are, they are composed of even tinier elementary particles known as quarks, which come in a variety of "flavors," or types: up, down, strange, charm, bottom and top. Typically, a proton is thought to be made of two up quarks and one down quark.
But a new study finds it's more complicated than that. Protons can also contain a charm quark, an elementary particle that's 1.5 times the mass of the proton itself. Even weirder, when the proton does contain the charm quark, the heavy particle still only carries about half the proton's mass.
The finding all comes down to the probabilistic world of quantum physics. Though the charm quark is heavy, the chance of it popping into existence in a proton is fairly small, so the high mass and small chance basically cancel each other out. Put another way, the full mass of the charm quark doesn't get taken up by the proton, even if the charm quark is there, Science News reported.
Though protons are fundamental to the structure of atoms — which make up all matter — they're also very complicated. Physicists don't actually know protons' fundamental structure. Quantum physics holds that beyond the up and down quarks known to be present, other quarks might pop into protons now and then, Stefano Forte, a physicist at the University of Milan, told the podcast Nature Briefing. Forte was a co-author of the new paper showing evidence for the charm quark in protons, published in the journal Nature Aug. 17.
There are six types of quarks. Three are heavier than protons and three are lighter than protons. The charm quark is the lightest of the heavy batch, so researchers wanted to start with that one to find out whether a proton could contain a quark heavier than itself. They did this by taking a new approach to 35 years of particle-smashing data.
To learn about the structure of subatomic and elementary particles, researchers fling particles against each other at blistering speeds at particle accelerators such as the Large Hadron Collider, the world's largest atom smasher, located near Geneva. Scientists with the nonprofit NNPDF collaboration gathered this particle-smashing data going back to the 1980s, including examples of experiments in which photons, electrons, muons, neutrinos and even other protons were crashed into protons. By looking at the debris from these collisions, researchers can reconstruct the original state of the particles.
In the new study, the scientists handed over all of this collision data to a machine-learning algorithm designed to look for patterns without any preconceived notions of how the structures might look. The algorithm returned possible structures and the likelihood that they might actually exist.
The study found a "small but not negligible" chance of finding a charm quark, Forte told Nature Briefing. The level of evidence wasn't high enough for the researchers to declare the undeniable discovery of the charm quark in protons, but the results are the "first solid evidence" that it can be there, Forte said.
The structure of the proton is important, Forte said, because to discover new elementary particles, physicists will have to uncover minuscule differences in what theories suggest and what's actually observed. This requires extremely precise measurements of subatomic structures.
For now, physicists still need more data on the elusive "charm" within a proton. Future experiments, such as the planned Electron-Ion Collider at Brookhaven National Laboratory in Upton, New York, may help, Tim Hobbs, a theoretical physicist at Fermilab in Batavia, Illinois, told Science News.
News
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]















